NEFL and COVID-19: The poor correlation between serum and CSF has important implications for future biomarker studies in the acute setting, suggesting that serum NfL may not be a reliable marker of CNS disease, and that CSF may be required to reliably detect or track neuronal damage in acute COVID-19.